Personalized neoantigen vaccines show promise in activating immune responses and controlling tumors in kidney cancer patients. A phase 1 trial demonstrated neoantigen-specific T-cell responses and ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin cancer who were ...
With the help of mRNA technology proven effective during the COVID pandemic, researchers are now closer than ever to creating viable cancer vaccines. In an interview with Wired, Lennard Lee, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results